Principia Biopharma Inc. (PRNB) Financial Statements (2024 and earlier)

Company Profile

Business Address 220 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2020
MRQ
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 315,580176,925
Cash and cash equivalents 39,53734,489
Short-term investments 276,043142,436
Restricted cash and investments  82
Prepaid expense 2,8931,661
Other undisclosed current assets 1,2722,104
Total current assets: 319,745180,772
Noncurrent Assets
Property, plant and equipment 9,6871,666
Long-term investments and receivables 52,2573,712
Long-term investments 52,2573,712
Restricted cash and investments 567567
Other noncurrent assets 4808,804
Total noncurrent assets: 62,99114,749
TOTAL ASSETS: 382,736195,521
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 9,1679,744
Employee-related liabilities 6,7154,312
Accounts payable 1,8504,439
Accrued liabilities 602993
Deferred rent credit 1,181 
Other undisclosed current liabilities 5,7917,136
Total current liabilities: 16,13916,880
Noncurrent Liabilities
Liabilities, other than long-term debt 7,6198,781
Deferred rent credit 7,6198,781
Total noncurrent liabilities: 7,6198,781
Total liabilities: 23,75825,661
Equity
Equity, attributable to parent 358,978169,860
Common stock 32
Additional paid in capital 544,709302,393
Accumulated other comprehensive income (loss) 9(128)
Accumulated deficit (185,743)(132,407)
Total equity: 358,978169,860
TOTAL LIABILITIES AND EQUITY: 382,736195,521

Income Statement (P&L) ($ in thousands)

6/30/2020
TTM
12/31/2019
12/31/2018
Revenues 35,16069,137
Gross profit: 35,16069,137
Operating expenses (93,925)(51,995)
Operating income (loss): (58,765)17,142
Nonoperating income 4,9731,025
Investment income, nonoperating 4,9731,678
Other nonoperating expense  (653)
Income (loss) from continuing operations before income taxes: (53,792)18,167
Income tax expense  (1)
Income (loss) from continuing operations: (53,792)18,166
Income (loss) before gain (loss) on sale of properties: (53,792)18,166
Other undisclosed net income  1
Net income (loss) attributable to parent: (53,792)18,167
Undistributed earnings (loss) allocated to participating securities, basic  (13,250)
Net income (loss) available to common stockholders, diluted: (53,792)4,917

Comprehensive Income ($ in thousands)

6/30/2020
TTM
12/31/2019
12/31/2018
Net income (loss): (53,792)18,167
Comprehensive income (loss): (53,792)18,167
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 137(38)
Comprehensive income (loss), net of tax, attributable to parent: (53,655)18,129

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: